Loading...
Loading...
India's dasatinib imports from ROMANIA total $249 across 1 shipments from 1 foreign suppliers. NEW LIFE BIOPHARMA LIMITED leads with $249 in import value; the top 5 suppliers together control 100.0% of this origin. Leading Indian buyers include INTAS PHARMACEUTICALS LIMITED. This corridor reflects India's pharmaceutical import demand for dasatinib โ a concentrated sourcing relationship with select suppliers from ROMANIA.

NEW LIFE BIOPHARMA LIMITED is the leading Dasatinib supplier from ROMANIA to India, with import value of $249 across 1 shipments. The top 5 suppliers โ NEW LIFE BIOPHARMA LIMITED โ collectively account for 100.0% of total import value from this origin.
Ranked by import value (USD) ยท Indian Customs (DGFT) data
| # | Supplier | Value (USD) | Shipments | Share |
|---|---|---|---|---|
| 1 | NEW LIFE BIOPHARMA LIMITED | $249 | 1 | 100.0% |
Ranked by import value (USD)
| # | Buyer | Value (USD) | Shipments | Share |
|---|---|---|---|---|
| 1 | INTAS PHARMACEUTICALS LIMITED | $249 | 1 | 100.0% |
Answers based on Indian Customs (DGFT) import records compiled by TransData Nexus
The top Dasatinib suppliers from ROMANIA to India include NEW LIFE BIOPHARMA LIMITED. The leading supplier is NEW LIFE BIOPHARMA LIMITED with import value of $249 USD across 1 shipments. India imported Dasatinib worth $249 USD from ROMANIA in total across 1 shipments.
India imported Dasatinib worth $249 USD from ROMANIA across 1 shipments. Data is from Indian Customs (DGFT) records. Values are in USD.
The main Indian buyers of Dasatinib sourced from ROMANIA include INTAS PHARMACEUTICALS LIMITED. The largest buyer is INTAS PHARMACEUTICALS LIMITED with $249 in imports across 1 shipments.
The total value of Dasatinib imports from ROMANIA to India is $249 USD, across 1 shipments and 1 foreign suppliers. Data source: Indian Customs (DGFT).
Pharmaceutical Export-Import Analyst & Trade Intelligence Expert
Suresh Sormare is a pharmaceutical export-import analyst with deep expertise in Indian Customs (DGFT) data, HS code classification, and global pharmaceutical supply chains. His analysis covers 10M+ shipment records across 150+ countries and is used by manufacturers, procurement agencies, and trade consultants worldwide. Suresh specializes in identifying verified suppliers and buyers from customs records, mapping bilateral pharmaceutical trade corridors, analyzing tariff structures and regulatory frameworks across 170+ destination markets, and benchmarking competitive positioning for finished pharmaceutical formulations. His methodology combines granular customs transaction data with regulatory intelligence from FDA, EMA, WHO, CDSCO, and 40+ national drug authorities to deliver actionable trade insights for the pharmaceutical formulations sector.
linkedin.com/in/sureshsormareAll trade data is sourced from Indian Customs (DGFT) official shipping bill records โ the authoritative government database for India's pharmaceutical trade. Each verified record contains exporter name, consignee (buyer) name, detailed product description, quantity, declared FOB value (USD), port of loading, destination country, and shipment date.
Data sourced from Indian Customs (DGFT) records. Verify regulatory and trade status with the agencies above.
Government-Sourced Data
Official DGFT customs records
Transparent Methodology
Calculations fully disclosed above
1 Verified Shipments
1 suppliers, 1 buyers tracked
Expert-Reviewed
By pharmaceutical trade specialists